TrialHuman vaccines & immunotherapeutics2021

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults.

Antonios O Aliprantis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.